Our Resources

Analyses and regulatory watch

Insights, lessons learned and news on data integrity in regulated industries.

Original analysisWritten by Veridata Advisory

AI and GxP: it’s not the tool that matters, it’s the use case

Should ChatGPT or Claude be validated in a GxP environment? The question is misleading. Find out why intended use determines the risk — and what the FDA now expects.

Curated updatesCommented external sources

FDA.gov — September 25, 2026

FDA Warning Letter citing data integrity deviations

Received a Data Integrity or CSV observation? Click here to discover our dedicated support. Received a Data Integrity or CSV observation? Click here to discover our dedicated support.